Cancer Communications
indexed by SCI
BMC


LETTER TO THE EDITOR
Long noncoding RNA PVT1 promotes tumor growth and predicts poor prognosis in patients with diffuse large B-cell lymphoma
Ruifeng Yang, Tingting Shao, Manmei Long, Yongheng Shi, Qiang Liu, Linhua Yang, Ming Zhan
[ [ Abstract  0]    [ PDF Full-text  0]    [ PubMed]   Epub: 7/29/2020   doi:10.1002/cac2.12073
ORIGINAL ARTICLE
miR-495 and miR-5688 are down-regulated in non-small cell lung cancer under hypoxia to maintain interleukin-11 expression
Meng Zhao, Jiao Chang, Ran Liu, Yahui Liu, Jin Qi, Yanhui Wang, Xinwei Zhang, Lu Qiao, Yu Jin, Haohua An, Li Ren
[ [ Abstract  0]    [ PDF Full-text  0]    [ PubMed]   Epub: 7/28/2020   doi:10.1002/cac2.12076
LETTER TO THE EDITOR
Long non-coding RNA MILNR1 retards colorectal cancer growth by inhibiting c-Myc
Hao Gu, Yang Xia, Lili Guo, Zifei Wang, Shuang Wu, Yuan Xu, Yaqin Zhang, Jing Huang Yu, Lei Wang,lai Hu
[ [ Abstract  0]    [ PDF Full-text  0]    [ PubMed]   Epub: 7/22/2020   doi:10.1002/cac2.12079
REVIEW
T-cell receptor repertoire analysis for the diagnosis and treatment of solid tumor: A methodology and clinical applications
Na Li, Jiani Yuan, Wenjia Tian, Lin Meng, Yongyu Liu
[ [ Abstract  0]    [ PDF Full-text  0]    [ PubMed]   Epub: 7/17/2020   doi:10.1002/cac2.12074
LETTER TO THE EDITOR
Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors
Qiuji Wu, Qian Chu, Hongyan Zhang, Bin Yang, Xudong He, Yahua Zhong, Xianglin Yuan, Melvin L.K. Chua, Conghua Xie
[ [ Abstract  0]    [ PDF Full-text  0]    [ PubMed]   Epub: 7/15/2020   doi:10.1002/cac2.12077
REVIEW
Single-cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy
Shuning Ding, Xiaosong Chen, Kunwei Shen
[ [ Abstract  0]    [ PDF Full-text  0]    [ PubMed]   Epub: 7/12/2020   doi:10.1002/cac2.12078
LETTER TO THE EDITOR
Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non-small cell lung cancer
Zhihuan Lin, Yaxiong Zhang
[ [ Abstract  0]    [ PDF Full-text  0]    [ PubMed]   Epub: 7/8/2020   doi:10.1002/cac2.12070
ORIGINAL ARTICLE
Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients
Zhong-Guo, Zhou, Jin-Bin Chen, Rong-Xin Zhang, Ling Ye, Jun-Cheng Wang, Yang-Xun Pan, Xiao-Hui Wang, Wen-Xuan Li, Yao-Jun Zhang, Li Xu, Min-Shan Chen
[ [ Abstract  0]    [ PDF Full-text  0]    [ PubMed]   Epub: 7/1/2020   doi:10.1002/cac2.12069
ORIGINAL ARTICLE
A phase I study of toripalimab, an anti-PD-1 antibody, in patients with refractory malignant solid tumors
Xiao-Li Wei, Chao Ren, Feng-Hua Wang, Yang Zhang, Hong-Yun Zhao, Ben-Yan Zou, Zhi-Qiang Wang, Miao-Zhen Qiu, Dong-Sheng Zhang, Hui-Yan Luo, Feng Wang, Sheng Yao, Rui-Hua Xu
[ [ Abstract  0]    [ PDF Full-text  0]    [ PubMed]   Epub: 6/26/2020   doi:10.1002/cac2.12068
ORIGINAL ARTICLE
A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis
Jie Wu, Huibo Zhang, Lan Li, Mengxue Hu, Liang Chen, Bin Xu, Qibin Song
[ [ Abstract  0]    [ PDF Full-text  0]    [ PubMed]   Epub: 6/18/2020   doi:10.1002/cac2.12067

<<    Page 53 of 81  >>    




CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China